- Home
- RCKT vs DFIN Comparison
RCKT vs DFIN Comparison
Compare RCKT & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- DFIN
- Stock Information
- Founded
- RCKT 1999
- DFIN 1983
- Country
- RCKT United States
- DFIN United States
- Employees
- RCKT N/A
- DFIN N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- DFIN Other Consumer Services
- Sector
- RCKT Health Care
- DFIN Consumer Discretionary
- Exchange
- RCKT Nasdaq
- DFIN Nasdaq
- Market Cap
- RCKT 1.3B
- DFIN 1.9B
- IPO Year
- RCKT N/A
- DFIN N/A
- Fundamental
- Price
- RCKT $12.72
- DFIN $60.68
- Analyst Decision
- RCKT Strong Buy
- DFIN Strong Buy
- Analyst Count
- RCKT 11
- DFIN 3
- Target Price
- RCKT $50.27
- DFIN $76.33
- AVG Volume (30 Days)
- RCKT 1.6M
- DFIN 220.6K
- Earning Date
- RCKT 02-24-2025
- DFIN 02-18-2025
- Dividend Yield
- RCKT N/A
- DFIN N/A
- EPS Growth
- RCKT N/A
- DFIN 18.18
- EPS
- RCKT N/A
- DFIN 3.18
- Revenue
- RCKT N/A
- DFIN $802,100,000.00
- Revenue This Year
- RCKT N/A
- DFIN $1.75
- Revenue Next Year
- RCKT $233,736.97
- DFIN $4.27
- P/E Ratio
- RCKT N/A
- DFIN $19.71
- Revenue Growth
- RCKT N/A
- DFIN 1.74
- 52 Week Low
- RCKT $11.15
- DFIN $56.02
- 52 Week High
- RCKT $31.47
- DFIN $71.01
- Technical
- Relative Strength Index (RSI)
- RCKT 47.75
- DFIN 45.11
- Support Level
- RCKT $11.56
- DFIN $60.24
- Resistance Level
- RCKT $12.32
- DFIN $63.74
- Average True Range (ATR)
- RCKT 0.71
- DFIN 1.61
- MACD
- RCKT 0.20
- DFIN 0.08
- Stochastic Oscillator
- RCKT 66.81
- DFIN 16.28
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a global risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( US), Europe, Asia, Canada, and others, of which the US accounts for the vast majority of its total revenue.